Is Trump Secretly Taking an Alzheimer’s Drug?

A California congresswoman has ignited fresh controversy in Washington with a stunning claim — suggesting President Donald Trump may be undergoing treatment for Alzheimer’s disease.

Rep. Sydney Kamlager-Dove, a Democrat from South Los Angeles, took to social media this week to question whether Trump, 79, has been using Leqembi — a $26,500-a-year anti-Alzheimer’s medication typically given through IV infusions.

“I’m just asking questions,” Kamlager-Dove wrote on X, attaching photos of Trump’s visibly bruised hand and referencing his recent disclosure that he had taken multiple cognitive tests.

The post came shortly after White House Press Secretary Karoline Leavitt faced a tense round of questioning about Trump’s health, particularly his bandaged hand and fatigue during recent public events.

“The Oval Office is like Grand Central Terminal,” Leavitt said. “The president is constantly shaking hands. He takes a daily aspirin — that’s all there is to it.”

Kamlager-Dove, however, wasn’t convinced. She first floated the Leqembi theory on December 4, claiming the bruises on Trump’s hand and his drowsiness were “consistent with known side effects of Alzheimer’s medications.”

In a statement to The Daily Beast, she added, “I’m not a doctor, but I do think it’s curious that the bruising and tiredness line up with Leqembi’s common side effects.”

Leqembi, developed by Japanese company Eisai, is designed to slow cognitive decline in early Alzheimer’s patients. It requires biweekly IV infusions and routine MRIs to monitor for dangerous brain swelling or microbleeds — side effects known as ARIA (Amyloid-Related Imaging Abnormalities).

According to the Alzheimer’s Association, those with a parent or sibling who suffered from the disease are at higher risk. Trump’s father, Fred Trump, battled Alzheimer’s for years before his death in 1999.

The White House reacted furiously to Kamlager-Dove’s speculation.

“It seems as if the Congresswoman has not been taking her medication,” spokesperson Steven Cheung said. “She is hallucinating, distorting reality in a clearly troublesome state that requires urgent medical care.”

Administration officials have consistently denied that Trump is ill, insisting he remains “sharp, energetic, and fully engaged.”

But questions have persisted since Trump underwent an unexplained MRI at Walter Reed Medical Center on October 10. Officials later described it as a “preventative” scan of his heart and abdomen — an explanation that several medical professionals have publicly doubted.

Trump has been seen nodding off during meetings and struggling to stay alert at public events — behavior supporters attribute to his famously short sleep schedule.

“He barely sleeps,” one senior aide told Politico in November. “He’s wired 24/7.”

Yet Alzheimer’s experts warn that excessive fatigue and disrupted sleep cycles can also be symptoms of early cognitive decline.

At a rally in the Poconos earlier this month, Trump appeared to lose his train of thought mid-sentence, sparking viral clips and renewed scrutiny of his mental sharpness. Days later, he boasted on Truth Social that he had “aced three cognitive tests,” though he did not specify when or where they took place.

Kamlager-Dove is the latest Democrat to raise alarms about the president’s health — a topic long considered taboo in official circles.

“Americans deserve transparency,” she said in a follow-up post Wednesday evening. “If he’s fit for office, let’s see the medical proof.”

Leqembi, which can delay severe cognitive decline by up to five months, remains one of the most expensive Alzheimer’s drugs on the market. It’s typically prescribed only after formal cognitive testing and MRI confirmation of brain amyloid buildup.

As rumors swirl, both sides appear to be digging in.

“Trump’s hand bruises aren’t from infusions — they’re from shaking too many hands,” a White House aide said, half-jokingly.

But Kamlager-Dove insists she’s not laughing. “The American people have a right to know what’s going on,” she said. “If he’s receiving a treatment that affects cognition or alertness, we should be told.”

Trump’s health has been a political lightning rod since his first term. His annual physicals have often sparked speculation, from his undisclosed 2019 visit to Walter Reed to repeated boasts about “acing” mental acuity tests.

With his second term now in full swing, the debate over his fitness — and transparency — is flaring back to life.